blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3761979

EP3761979 - USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.08.2024
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  12.01.2024
FormerRequest for examination was made
Status updated on  11.12.2020
FormerThe international publication has been made
Status updated on  12.10.2019
Most recent event   Tooltip30.08.2024Application deemed to be withdrawnpublished on 02.10.2024  [2024/40]
Applicant(s)For all designated states
Ovid Therapeutics Inc.
1460 Broadway
New York, New York 10036 / US
[2021/02]
Inventor(s)01 / DURING, Matthew
14 Cedar Lane
Weston, Connecticut 06883 / US
 [2021/02]
Representative(s)Laufhütte, Dieter
Lorenz Seidler Gossel
Rechtsanwälte Patentanwälte
Partnerschaft mbB
Widenmayerstraße 23
80538 München / DE
[2021/02]
Application number, filing date19781960.006.04.2019
[2021/02]
WO2019US26218
Priority number, dateUS201862653641P06.04.2018         Original published format: US 201862653641 P
US201862654786P09.04.2018         Original published format: US 201862654786 P
[2021/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019195813
Date:10.10.2019
Language:EN
[2019/41]
Type: A1 Application with search report 
No.:EP3761979
Date:13.01.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 10.10.2019 takes the place of the publication of the European patent application.
[2021/02]
Search report(s)International search report - published on:US10.10.2019
(Supplementary) European search report - dispatched on:EP01.06.2021
ClassificationIPC:A61K31/437, A61K45/06, A61P25/30, A61P25/32, A61P25/34, A61P25/36
[2021/26]
CPC:
A61K31/437 (EP,IL,KR,US); A61K45/06 (EP,IL,KR,US); A61P25/32 (EP,IL,KR,US);
A61P25/34 (EP,IL,KR,US); A61P25/36 (EP,IL,KR,US); A61K2300/00 (IL,KR)
C-Set:
A61K31/437, A61K2300/00 (EP)
Former IPC [2021/02]A61K31/437, A61K45/06, A61P3/10
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/02]
TitleGerman:VERWENDUNG VON GABOXADOL ZUR BEHANDLUNG VON SUBSTANZMISSBRAUCH[2021/02]
English:USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS[2021/02]
French:UTILISATION DE GABOXADOL DANS LE TRAITEMENT DE TROUBLES LIÉS À L'USAGE DE SUBSTANCES[2021/02]
Entry into regional phase05.10.2020National basic fee paid 
05.10.2020Search fee paid 
05.10.2020Designation fee(s) paid 
05.10.2020Examination fee paid 
Examination procedure05.10.2020Examination requested  [2021/02]
03.12.2021Amendment by applicant (claims and/or description)
15.01.2024Despatch of a communication from the examining division (Time limit: M04)
16.05.2024Application deemed to be withdrawn, date of legal effect  [2024/40]
07.06.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/40]
Fees paidRenewal fee
27.04.2021Renewal fee patent year 03
27.04.2022Renewal fee patent year 04
27.04.2023Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
30.04.202406   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO0108675  (MOLTENI & C [IT], et al) [I] 1-11 * claim 1 *;
 [I]US2002042446  (DEWEY STEPHEN L [US], et al) [I] 1-11* claims 1, 5, 15, 17 *
International search[A]US2002165217  (HOWARD HARRY R [US]) [A] 1-40 * ; entire document *;
 [A]US2005192271  (LEGARDA IBANEZ JUAN J [ES]) [A] 1-40* ; entire document *;
 [Y]US2008207601  (SABNANI SANJAY [US]) [Y] 7-40 * ; Claim 48, para[0032], para[0049], para[0170], para[0171], para[0197] *;
 [X]US2009203731  (SANCHEZ CONNIE [DK], et al) [X] 1-6 * ; para[0009], para[0017], para[0018], para[0037] *;
 [Y]US2011082171  (FERGUSON MARK WILLIAM JAMES [GB], et al) [Y] 7-40 * ; Abstract *;
 [A]US2013053435  (LIANG JING [US], et al) [A] 1-40 * ; entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.